Long-term clinical results of autologous Platelet Rich Plasma (PRP) in recalcitrant plantar fasciitis

Ranjeet Choudhary, A. Agrawal, A. Garg, A. Inamdar, Shilp Verma
{"title":"Long-term clinical results of autologous Platelet Rich Plasma (PRP) in recalcitrant plantar fasciitis","authors":"Ranjeet Choudhary, A. Agrawal, A. Garg, A. Inamdar, Shilp Verma","doi":"10.18231/j.ijor.2021.004","DOIUrl":null,"url":null,"abstract":"In recent years, biologic therapies such as platelet-rich plasma (PRP) have gained prominence in multiple orthopedics degenerative tendinopathy and ligamental pathology. This research aimed to assess the clinical effectiveness of autologous platelet-rich plasma injection in cases of recalcitrant plantar fasciitis (RPF) over a long period.A prospective observational study was performed on RPF that did not experience pain relief after three months of conservative therapy. Under sterile conditions, inject approximately 3ml of platelet-rich plasma mixed with 0.5ml lignocaine into the maximum tender point of the heel. Visual Analogue Score for Pain, the American Orthopedics Foot, and Ankle Society (AOFAS) Ankle, and Hind Foot Score at one month, three months, six months, one year, and two years after injection.A total of 60 patients of RPF which 23 (38.33%) were male, and the rest 37 (61.66%) were female. The mean age was 45 ± 7.25 and the mean duration of symptoms was 7.4 ± 2.1months. The mean VAS score was 7.92 ± 1.2 at pre-injection, was progressively reduced post-injection to 5.61 ± 1.56 at one month, 3.1 ± .83 at three months, and 2.4 ± .68 at six months and remained at low level 2.5 ± .92 at one year and 2.7 ± .56 at two years. The mean AOFAS score was 56.92 ± 13.24 at pre-injection, was progressively increased post-injection to 66.41± 10.26 at one month, 78.31 ± 12.64 at three months, and 90.54 ± 10.71 at six months and remained at a low level 89.24 ± 8.92 at one year and 87.54 ±10.56 at two years. Mean VAS and AOFAS scores showed statistically significant pain reduction and functional improvements at successive follow-ups till 6month (p<.05); the improvement remained stable and did not change significantly until the last appointment at 2year follow-up (p > 0.05).The outcomes of autologous PRP injection in recalcitrant plantar fasciitis are reliable, stable, and predictable in both long- and short-term follow-up. PRP injection is safer and not associated with serious complications as in the case of steroid injection.","PeriodicalId":274774,"journal":{"name":"IP International Journal of Orthopaedic Rheumatology","volume":"16 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"IP International Journal of Orthopaedic Rheumatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18231/j.ijor.2021.004","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

In recent years, biologic therapies such as platelet-rich plasma (PRP) have gained prominence in multiple orthopedics degenerative tendinopathy and ligamental pathology. This research aimed to assess the clinical effectiveness of autologous platelet-rich plasma injection in cases of recalcitrant plantar fasciitis (RPF) over a long period.A prospective observational study was performed on RPF that did not experience pain relief after three months of conservative therapy. Under sterile conditions, inject approximately 3ml of platelet-rich plasma mixed with 0.5ml lignocaine into the maximum tender point of the heel. Visual Analogue Score for Pain, the American Orthopedics Foot, and Ankle Society (AOFAS) Ankle, and Hind Foot Score at one month, three months, six months, one year, and two years after injection.A total of 60 patients of RPF which 23 (38.33%) were male, and the rest 37 (61.66%) were female. The mean age was 45 ± 7.25 and the mean duration of symptoms was 7.4 ± 2.1months. The mean VAS score was 7.92 ± 1.2 at pre-injection, was progressively reduced post-injection to 5.61 ± 1.56 at one month, 3.1 ± .83 at three months, and 2.4 ± .68 at six months and remained at low level 2.5 ± .92 at one year and 2.7 ± .56 at two years. The mean AOFAS score was 56.92 ± 13.24 at pre-injection, was progressively increased post-injection to 66.41± 10.26 at one month, 78.31 ± 12.64 at three months, and 90.54 ± 10.71 at six months and remained at a low level 89.24 ± 8.92 at one year and 87.54 ±10.56 at two years. Mean VAS and AOFAS scores showed statistically significant pain reduction and functional improvements at successive follow-ups till 6month (p<.05); the improvement remained stable and did not change significantly until the last appointment at 2year follow-up (p > 0.05).The outcomes of autologous PRP injection in recalcitrant plantar fasciitis are reliable, stable, and predictable in both long- and short-term follow-up. PRP injection is safer and not associated with serious complications as in the case of steroid injection.
自体富血小板血浆(PRP)治疗顽固性足底筋膜炎的长期临床观察
近年来,富血小板血浆(PRP)等生物疗法在多种骨科退行性肌腱病和韧带病理中得到了突出的应用。本研究旨在评估自体富血小板血浆注射治疗顽固性足底筋膜炎(RPF)长期的临床疗效。一项前瞻性观察研究对保守治疗三个月后疼痛未缓解的RPF患者进行了研究。在无菌条件下,将约3ml富血小板血浆与0.5ml利多卡因混合注入足跟最大压痛点。注射后1个月、3个月、6个月、1年和2年的疼痛视觉模拟评分、美国骨科足和踝关节协会(AOFAS)踝关节和后足评分。共60例RPF患者,其中男性23例(38.33%),女性37例(61.66%)。患者平均年龄45±7.25岁,平均症状持续时间7.4±2.1个月。注射前平均VAS评分为7.92±1.2分,注射后逐渐降低至1个月5.61±1.56分,3个月3.1±0.83分,6个月2.4±0.68分,1年2.5±0.92分,2年2.7±0.56分维持在较低水平。注射前平均AOFAS评分为56.92±13.24,注射后逐渐升高至66.41±10.26(1个月),78.31±12.64(3个月),90.54±10.71(6个月),维持在89.24±8.92(1年)和87.54±10.56(2年)的低水平。VAS和AOFAS平均评分在连续随访至6个月时疼痛减轻和功能改善具有统计学意义(p 0.05)。在长期和短期随访中,自体PRP注射治疗顽固性足底筋膜炎的结果是可靠、稳定和可预测的。与类固醇注射相比,PRP注射更安全,没有严重的并发症。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信